» Articles » PMID: 25207211

The Impact of Overweight and Obesity on Breast Cancer: Data from Switzerland, So Far a Country Little Affected by the Current Global Obesity Epidemic

Overview
Journal Gland Surg
Specialty Endocrinology
Date 2014 Sep 11
PMID 25207211
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This review presents results from the project "The Impact of Overweight/Obesity on Breast Cancer: data from Switzerland". Swiss data is interesting because the general female population is distinctive in two areas when compared to that of most other industrialized countries: Switzerland has comparatively low rates of overweight (22-23%) and obesity (7-8%) and has rather stable rates of overweight and obesity. The entire project comprised three major issues: (I) etiology of breast cancer (BC). There is a consistently shown association between obesity and postmenopausal BC risk in countries with high obesity prevalence rates in the literature. In our Swiss study group, however, we did not find higher rates of overweight and obesity in postmenopausal BC cases than in the general population. A possible explanation for this observation may be a curvilinear dose-response relationship between BMI and postmenopausal BC risk, so that an increased risk may only be observed in populations with a high prevalence of obese/very obese women; (II) tumor characteristics. BMI was significantly associated with tumor size; this applied not only to the cases where the tumor was found by self-detection, but also to lesions detected by radiological breast examinations. In addition, a higher BMI was positively correlated with advanced TNM stage, unfavorable grading and a higher St. Gallen risk score. No associations were observed between BMI and histological subtype, estrogen receptor status, HER2 status and triple negative BC; (III) patient compliance and persistence towards adjuvant BC therapy. Many studies found that the prognosis of overweight/obese BC patients was significantly lower than that of normal weight patients. However, failure of compliance and persistence towards therapy on the part of the patient is not a contributing factor for this observed unfavorable prognosis. In most therapy modes, patients with increasing BMI demonstrated greater motivation and perseverance towards the recommended treatment.

Citing Articles

Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer.

Zangouri V, Balaneji S, Golmoradi R, Kafili E, Bologhi S, Mousavi S BMC Cancer. 2025; 25(1):257.

PMID: 39948483 PMC: 11827321. DOI: 10.1186/s12885-025-13638-7.


The food environment and postdiagnosis weight gain among Black women breast cancer survivors in Maryland.

Ho K, Tu Y, Dibble K, Visvanathan K, Connor A Breast Cancer Res Treat. 2024; 209(2):253-259.

PMID: 39522089 DOI: 10.1007/s10549-024-07543-z.


Disparities in breast cancer mortality among Latin American women: trends and predictions for 2030.

Torres-Roman J, Ybaseta-Medina J, Loli-Guevara S, Bazalar-Palacios J, Valcarcel B, Arce-Huamani M BMC Public Health. 2023; 23(1):1449.

PMID: 37507674 PMC: 10386226. DOI: 10.1186/s12889-023-16328-w.


Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis.

Zhang F, de Haan-Du J, Sidorenkov G, Landman G, Jalving M, Zhang Q Cancers (Basel). 2021; 13(19).

PMID: 34638475 PMC: 8508341. DOI: 10.3390/cancers13194992.


Using data mining technology to predict medication-taking behaviour in women with breast cancer: A retrospective study.

Kuo C, Wang H, Tseng L Nurs Open. 2021; 9(6):2646-2656.

PMID: 34156764 PMC: 9584494. DOI: 10.1002/nop2.963.


References
1.
Protani M, Coory M, Martin J . Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010; 123(3):627-35. DOI: 10.1007/s10549-010-0990-0. View

2.
Berz D, Sikov W, Colvin G, Weitzen S . 'Weighing in' on screening mammography. Breast Cancer Res Treat. 2008; 114(3):569-74. DOI: 10.1007/s10549-008-0037-y. View

3.
Kaaks R, van Noord P, Den Tonkelaar I, Peeters P, Riboli E, Grobbee D . Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch "DOM" cohort. Int J Cancer. 1998; 76(5):647-51. DOI: 10.1002/(sici)1097-0215(19980529)76:5<647::aid-ijc6>3.0.co;2-q. View

4.
Eichholzer M, Huang D, Modlasiak A, Schmid S, Schotzau A, Rohrmann S . Impact of body mass index on prognostically relevant breast cancer tumor characteristics. Breast Care (Basel). 2014; 8(3):192-8. PMC: 3728633. DOI: 10.1159/000350002. View

5.
Chlebowski R, Aiello E, McTiernan A . Weight loss in breast cancer patient management. J Clin Oncol. 2002; 20(4):1128-43. DOI: 10.1200/JCO.2002.20.4.1128. View